Additional Information

Alka Dwivedi received her Ph.D. degree from the Indian Institute of Technology, Bombay, India in 2021; her research focused on developing indigenous CD19 CAR T cell therapy for leukemia and lymphoma patients. Then in 2021, she joined the Taylor lab as a postdoctoral fellow. Currently, she is working on developing novel strategies with CAR T cells for the treatment of AML and ALL.